Nature Search

Markedly enhanced intratumoral spread and antitumor effect of oncolytic adenovirus expressing decorin

Chae-Ok Yun
Joo-Hang Kim
Daniela Seidler
ResearchOpen Access03 Jan 2008
Nature Precedings

P: 1
SEZ6-targeting antibody−drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial

As presented at the 2026 ASCO Annual Meeting, in a phase 1 trial, treatment of patients with the seizure-related homolog protein 6 (SEZ6)-targeting antibody−drug conjugate ABBV-706 demonstrated a manageable safety profile and showed preliminary clinical efficacy in patients with resistant or refractory small cell lung cancer.

Lauren Averett Byers
Byoung Chul Cho
Sreenivasa Chandana
ResearchOpen Access01 Jun 2026
Nature Medicine

P: 1-11
Identification of MARCKS, FLJ11383 and TAF1B as putative novel target genes in colorectal carcinomas with microsatellite instability

Nam-Gyun Kim
Hwanseok Rhee
Hoguen Kim
Research29 Jul 2002
Oncogene

Volume: 21, P: 5081-5087
A randomised phase 2b study comparing the efficacy and safety of belotecan vs. topotecan as monotherapy for sensitive-relapsed small-cell lung cancer

Jin-Hyoung Kang
Ki-Hyeong Lee
Heung Tae Kim
ResearchOpen Access16 Nov 2020
British Journal of Cancer

Volume: 124, P: 713-720
Exome sequencing reveals recurrent REV3L mutations in cisplatin-resistant squamous cell carcinoma of head and neck

Kie Kyon Huang
Kang Won Jang
Byoung Chul Cho
ResearchOpen Access21 Jan 2016
Scientific Reports

Volume: 6, P: 1-10
Antitumor effects of IL-12 and GM-CSF co-expressed in an engineered oncolytic HSV-1

Kyoung-Ju Kim
Dahye Moon
Kyung-Ju Choi
Research04 Nov 2020
Gene Therapy

Volume: 28, P: 186-198
Correlation of KIT and platelet-derived growth factor receptor α mutations with gene activation and expression profiles in gastrointestinal stromal tumors

Hyun Ju Kang
Suk Woo Nam
Hoguen Kim
Research27 Dec 2004
Oncogene

Volume: 24, P: 1066-1074
Immune gene signatures for predicting durable clinical benefit of anti-PD-1 immunotherapy in patients with non-small cell lung cancer

Sohyun Hwang
Ah-Young Kwon
Hee Jung An
ResearchOpen Access20 Jan 2020
Scientific Reports

Volume: 10, P: 1-10
ADP-overexpressing adenovirus elicits enhanced cytopathic effect by induction of apoptosis

Chae-Ok Yun
Eunhee Kim
Joo-Hang Kim
Research17 Sept 2004
Cancer Gene Therapy

Volume: 12, P: 61-71
Evaluation of E1B gene-attenuated replicating adenoviruses for cancer gene therapy

Jaesung Kim
Jae Yong Cho
Chae-Ok Yun
Research22 Aug 2002
Cancer Gene Therapy

Volume: 9, P: 725-736
Randomised Phase 2 study of maintenance linsitinib (OSI-906) in combination with erlotinib compared with placebo plus erlotinib after platinum-based chemotherapy in patients with advanced non-small cell lung cancer

Tudor-Eliade Ciuleanu
Samreen Ahmed
Fiona Blackhall
ResearchOpen Access03 Aug 2017
British Journal of Cancer

Volume: 117, P: 757-766

Search

Markedly enhanced intratumoral spread and antitumor effect of oncolytic adenovirus expressing decorin

SEZ6-targeting antibody−drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial

Identification of MARCKS, FLJ11383 and TAF1B as putative novel target genes in colorectal carcinomas with microsatellite instability

A randomised phase 2b study comparing the efficacy and safety of belotecan vs. topotecan as monotherapy for sensitive-relapsed small-cell lung cancer

Exome sequencing reveals recurrent REV3L mutations in cisplatin-resistant squamous cell carcinoma of head and neck

Antitumor effects of IL-12 and GM-CSF co-expressed in an engineered oncolytic HSV-1

Correlation of KIT and platelet-derived growth factor receptor α mutations with gene activation and expression profiles in gastrointestinal stromal tumors

Immune gene signatures for predicting durable clinical benefit of anti-PD-1 immunotherapy in patients with non-small cell lung cancer

ADP-overexpressing adenovirus elicits enhanced cytopathic effect by induction of apoptosis

Evaluation of E1B gene-attenuated replicating adenoviruses for cancer gene therapy

Randomised Phase 2 study of maintenance linsitinib (OSI-906) in combination with erlotinib compared with placebo plus erlotinib after platinum-based chemotherapy in patients with advanced non-small cell lung cancer

Search

Quick links

Search

Filter By:

Search

Quick links